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Background: Androgen receptor (AR) is the principle therapeutic target in prostate cancer.
Result: We have established that Usp12 deubiquitinates and stabilizes the AR resulting in increased transcriptional and pro-
proliferative activity.
Conclusion:We have identified Usp12 to be a novel positive regulator of AR.
Significance: Usp12 presents a therapeutic target upstream of AR that could enable bypassing the limitations of therapeutics
aimed specifically at AR.
The androgen receptor (AR), a member of the nuclear recep-
tor family, is a transcription factor involved in prostate cell
growth, homeostasis, and transformation. AR is a key protein in
growth and development of both normal and malignant pros-
tate, making it a common therapeutic target in prostate cancer.
AR is regulated by an interplay of multiple post-translational
modifications including ubiquitination. We and others have
shown that the AR is ubiquitinated by a number of E3 ubiquitin
ligases, including MDM2, CHIP, and NEDD4, which can result
in its proteosomal degradation or enhanced transcriptional
activity. As ubiquitination of AR causes a change in AR activity
or stability and impacts both survival and growth of prostate
cancer cells, deubiquitination of these sites has an equally
important role. Hence, deubiquitinating enzymes could offer
novel therapeutic targets. We performed an siRNA screen to
identify deubiquitinating enzymes that regulate AR; in that
screen ubiquitin-specific protease 12 (Usp12) was identified as a
novel positive regulator of AR. Usp12 is a poorly characterized
protein with few known functions and requires the interaction
with two cofactors,Uaf-1 andWDR20, for its enzymatic activity.
In this reportwedemonstrate thatUsp12, in complexwithUaf-1
andWDR20, deubiquitinates theAR to enhance receptor stabil-
ity and transcriptional activity.Our data show thatUsp12 acts in
a pro-proliferative manner by stabilizing AR and enhancing its
cellular function.
The androgen receptor (AR)3 belongs to the nuclear hor-
mone receptor superfamily and plays a key role in the transcrip-
tional regulation of numerous genes important in the develop-
ment of both normal and malignant prostate (1). Ligand
binding of the AR in the cytoplasm results in dimerization,
translocation to the nucleus, and transcription of androgen-
responsive genes. Deregulation of AR signaling leads to the
development of prostate cancer (PCa), and as such the receptor
represents themost common therapeutic target in PCa (1). The
current clinical strategies in PCa revolve around anti-hormone
therapies and aim to pharmacologically decrease serum andro-
gen levels. This is currently achieved through the use of lutein-
izing hormone-releasing hormone agonists such as goserelin or
anti-androgens which can be either steroidal (cyproterone ace-
tate) or nonsteroidal (flutamide) and function by competitively
inhibiting the AR (2). However, despite initial success most of
anti-androgen therapieswill invariably fail resulting in castrate-
resistant prostate cancer (CRPCa). Importantly, the AR signal-
ing cascade remains functional in CRPCa. Treatment failure
can be caused by changes in AR signaling, including alterations
in AR cofactor levels and activity as well as emergence of AR
mutations that permit receptor activity in the presence of non-
androgenic steroids and anti-androgens (2). In CRPCa, AR still
remains a crucial target, with increased AR levels and gene
amplification observed in 30% of patients. Increased levels of
the downstream gene prostate-specific antigen (PSA) in the
serum are also associated with PCa recurrence (3). Previous
research demonstrated that even at CRPCa stage, depletion of
AR by siRNA treatment decreased tumor growth. Similarly, AR
overexpression in PCa xenograft in castrate animals still
enhanced cancer growth (4).
AR function and activity are known to be regulated by a num-
ber of post-translational modifications. In response to andro-
gens, AR is phosphorylated by kinases including AKT (5) and
TFIIH (6), resulting in changes to transcriptional activity and
cellular localization. This can be reversed by phosphatases such
as protein phosphatases 1 and 2A (7). Acetylation by p300 (8)
and Tip60 (9) enhances transcriptional activity which can be
reversed by the histone deacetylases HDAC1 (10) and SIRT1
(11). AR is also subjected to SUMOylation by PIAS1 and
PIASx, a process that is believed to decrease its transcriptional
activity (12). We and others have shown that the AR is also
* This work was supported by Prostate Cancer United Kingdom, Cancer
Research UK, and the Medical Research Council.
1 Both authors contributed equally to this work.
2 Towhom correspondence should be addressed. Tel.: 44-191-246-4426; Fax:
44-191-246-4301; E-mail: c.n.robson@ncl.ac.uk.
3 The abbreviations used are: AR, androgen receptor; ARE, androgen-respon-
sive element; CRPCa, castrate-resistant prostate cancer; DHT, dihydrotes-
tosterone; IP, immunoprecipitation; PCa, prostate cancer; PI, propidium
iodide; PSA, prostate-specific antigen; qPCR, quantitative PCR; SCR, scram-
bled; Usp, ubiquitin-specific protease.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 288, NO. 45, pp. 32641–32650, November 8, 2013
© 2013 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
NOVEMBER 8, 2013•VOLUME 288•NUMBER 45 JOURNAL OF BIOLOGICAL CHEMISTRY 32641
 at U
niversity of Liverpool on February 18, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ubiquitinated by a number of E3 ubiquitin ligases, including
MDM2 (13, 14), CHIP (15, 16), and NEDD4 (17, 18) which
results in proteosomal degradation. AR ubiquitination can also
lead to the increase in transcriptional activity; RNF6 has been
reported to ubiquitinate AR at Lys-845 and Lys-847, promoting
its activity by allowing ARA54 co-activator recruitment (19).
Further details of AR post-translational modifications have
been recently reviewed (20).
Ubiquitination of AR causes a change in AR activity and sta-
bility and impacts both survival and growth of PCa cells. As a
result deubiquitination of those sites has an equally important
role.
Currently, very little is known about the enzymes that deu-
biquitinate AR. It has been reported that Usp26 can directly
bind and deubiquitinate AR, acting as a co-regulator of AR by
reversing AR activation and degradation byMDM2 ubiquitina-
tion depending on cellular context (21). Additionally, Usp10
has been reported to bind AR, resulting in increased transcrip-
tional activity (22).
In this study we focused on Usp12, a deubiquitinating enzyme
identified in an siRNA screen as a positive regulator of AR.
Usp12 has three reported targets; histones H2B, H2A (23), and
nonactivatedNotch (24). Usp12 is highly homologous toUsp46
and Usp1, and its activity, similar to that of Usp46, is enhanced
by binding to its cofactors Uaf-1 and WDR20, with Uaf-1
required for enzymatic activity of Usp12 (25–27). It has been
reported that Uaf-1 binds and stabilizes Usp12, and this com-
plex is bound byWDR20. This interaction is both stoichiomet-
ric and evolutionarily conserved and has been shown to play the
same role in Schizosaccharomyces pombe (28). Usp12 and Uaf-
1-containing complex was shown to deubiquitinate all types
of ubiquitin chains apart from linear chains (27). Our search
of Oncomine profiles revealed that Usp12 is differentially
expressed in bladder, brain, CNS, cervical, kidney, lymphoma,
and ovarian cancer samples compared with healthy controls.
We now show that Usp12, in complex with Uaf-1 andWDR20,
interactswith anddeubiquitinates theAR resulting in increased
protein stability and transcriptional activity. Moreover, we
report that Usp12 depletion reduces PCa cell proliferation and
up-regulates cell apoptosis, suggesting that it is an additional
regulator of the AR that may represent a novel target for
therapy.
EXPERIMENTAL PROCEDURES
Antibodies and Plasmids—Antibodies used were anti-FLAG
(Sigma), anti-Usp12 (Dundee Cell Products), anti-AR (Santa
Cruz Biotechnology; N20 clone), anti-HA (Santa Cruz Biotech-
nology; Y11 clone), anti--tubulin (Sigma), and anti-ubiquitin
(Santa Cruz Biotechnology). Plasmids used were pPSA-Luc,
pARE3-Luc, pCMV--gal, pFLAG-His-AR (9), pFLAG-Usp12
wild type, and C48A mutant generated by in vitromutagenesis
(QuikChange; Stratagene), pHA-ubiquitin and pHA-FLAG-
WDR20 and pFLAG-Uaf-1 (25, 26), which were kind gifts from
Professor Alan D’Andrea (Dana-Farber Cancer Institute,
Boston).
Cell Culture, Transfections, and Reporter Assays—LNCaP,
HEK293T, andCOS-7 cells were obtained fromAmericanType
Culture Collection (Manassas, VA). VCaP cells were kindly
donated by Professor Guido Jenster (Erasmus Medical Centre,
Rotterdam). Cells were cultured in RPMI 1640 medium with 2
mM L-glutamine (Invitrogen) supplementedwith 10% (v/v) fetal
calf serum (FCS) at 37 °C in 5%CO2. LNCaP-AI variant cell line
was derived in-house by culturing LNCaP cells in steroid-de-
pleted medium (DCC) to allow for the development of andro-
gen independence (30). LNCaP-7B7 cells stably overexpressing
pPSA-Luc vector were kindly donated by Professor Jan Trap-
man (Erasmus Medical Centre) and cultured with the addition
of 25 g/ml zeocin. Transfections were performed using Tran-
sIT-LT1 reagent (MirusBiol) following the manufacturer’s
instructions.
For luciferase assays, cells were transfected with 50 ng of
pARE3-luc, 50 ng of pCMV--gal, and 10 ng of pFLAG-His-
AR, pFLAG-Usp12, and pFLAG-Uaf-1 as required. All reac-
tions were balanced with pCMV empty vector. Cells were cul-
tured under steroid-depleted conditions for 48 h followed by
supplementationwith dihydrotestosterone (DHT), at a range of
concentration of 5 and 10 nMwith comparable results obtained
for both concentrations, for an additional 24 h. Cells were lysed
and incubated in 1 Promega luciferase assay reagents accord-
ing to the manufacturer’s instruction, and luciferase counts/s
were established and normalized to -galactosidase activity.
Results were normalized to AR expression alone in steroid-
depleted conditions.
siRNA Gene Silencing and Gene Expression Analysis—The
generation andDUB siRNA screeningmethodology forAR reg-
ulators screen using an ELISA against PSA protein as a readout
of AR activity in LNCaP cells have been described previously
(29). Usp12 targeting siRNA sequences were: (A) GAAACUC-
UGUGCAGUGAAU[dTdT], (B) CAGAUCUCUUCCAUAG-
CAU[dTdT], and (C) CAUCAGAUAUCUCAAAGAA[dTdT];
WDR20 was silenced with siRNAs (A) CGAGAAAGAUCAC-
AAGCGA[dTdT] and (B) GUUUGACCCUUAUACCAC-
U[dTdT] andUaf-1with (A) CAAAUUGGUUCUCAGUAGA-
[dTdT] and (B)CAUUGACUGCCUCAAAUAA[dTdT]. Initial
DUB screen used a pool of siRNAs against Usp12, and further
experiments were performed using siRNA (B). Uaf-1 A achieved
61.5%knockdownwithUaf-1B61%similarly,WDR20Aachieved
67.4% andWDR20 B 57.4% in quantitative PCR (qPCR) valida-
tion (data not shown). As a result siRNAs (A) were selected for
silencing of both Uaf-1 and WDR20.
LNCaP cells were reverse transfected with siRNA using
RNAiMax (Invitrogen) according to the manufacturer’s instruc-
tions and incubated in culturemedium for 96 h prior to cell lysis
and analysis byWestern blotting as described previously (31) or
qPCR. For qPCR RNA was extracted using the EZ RNA isola-
tion kit (Biological Industries), and cDNA synthesis and data
analysis were performed as described previously (32). Prolifer-
ation was measured by cell counting 96 h after gene silencing.
To measure colony-forming ability cells were reverse trans-
fectedwith siRNA for 72 h, followed by reseeding at varying cell
densities and incubated for 14 days to allow colony formation
and stained with crystal violet. Colonies were counted and the
surviving fraction calculated (31).
Flow Cytometry—Cell cycle profiles were generated by pro-
pidium iodide (PI) staining, cells were permeabilized with 1%
Triton X-100 and incubated with 1 g/ml RNaseA and PI fol-
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lowed by analysis on FACScan (BD Biosciences) (33). Levels of
apoptosis were analyzed after 96 h of gene silencing by annexin
V assay (BD Biosciences) according to the manufacturer’s
instructions and analyzed on a FACScan. Cells were stained for
both annexin V and PI positivity and during analysis divided
into quarters representing normal cells, necrotic cells, and apo-
ptotic cells.
Immunoprecipitations (IPs)—Cells were seeded at 5  105
cells/90-mm dish, transfected 24 h later with 1 g of each plas-
mid as indicated, incubated for 48 h, and lysed directly into lysis
buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.2 mM Na3VO4, 1%
Nonidet P-40, 1 mM PMSF, 1 mMDTT, and 1 protease inhib-
itors (Roche Applied Science)). Lysates were incubated with 1
g of antibodies as indicated for 16 h at 4 º, and antibodies were
pulled down using protein G-Sepharose beads. For denaturing
IPs, cells were subject to 20 M MG132 proteosomal inhibitor
treatment for the final 16 h followed by collection into lysis
buffer with an addition of 2% SDS and denatured at 100 °C for
10 min (29). After denaturation samples were diluted 10 in
lysis buffer without SDS and processed as in native IP. Immu-
noprecipitants were analyzed using Western blotting.
Chromatin immunoprecipitations (ChIPs) were performed
as described previously (10). LNCaP cells were transfected in
steroid-depleted medium for 72 h followed by DHT treatment
for 120 min. Data are presented as percentage input using the
following formula: % input 100 2* (CT adjusted input sam-
ple  CT immunoprecipitated sample). CT refers to cycle
threshold.
Immunohistochemistry—Tissuemicroarray containing0.6-mm
cores of benign prostatic hyperplasia (n 7), PCa (n 7), and
control tissues including breast, kidney, placenta, ovary, and
liver was used. Antigens were retrieved by pressure cooking the
tissue microarray in 0.01 M citrate buffer, pH 6.0, followed by
staining the tissues with rabbit polyclonal anti-Usp12 antibody
(Dundee Cell Products) (29).
RESULTS
Identification of Usp12 as a Positive Regulator of AR—To
identify DUBs that regulate AR we conducted an siRNA screen
in LNCaP cells using an ELISA detecting the levels of PSA,
which is anAR target gene product, and as such its levels will be
affected by any change in AR activity, as a surrogate readout of
AR activity. All samples were normalized against the scrambled
control (SCR), and readouts of2-fold PSA protein level com-
pared with SCR were taken for further validation. To confirm
that target DUBs regulate AR transcriptional activity and not
only PSA secretion, further validation included the assessment
of PSA mRNA levels upon DUB depletion, eliminating DUBs
that solely affect PSA rather than AR activity. Of the 78
screened DUBs, four were identified as potentially involved in
androgen-dependent regulation of AR. Silencing of one of the
targets, Usp12, resulted in 73% reduction in PSA protein levels
(Fig. 1A, highlighted panel). This result was also confirmed by
Western blotting (Fig. 1B). Usp12 siRNA was shown to signifi-
cantly decrease Usp12 transcript levels in three PCa cell lines,
namely, LNCaP, LNCaP-AI, and VCaP (Fig. 1C). Additionally,
depletion of Usp12 resulted in significant decrease of PSA tran-
script in LNCaP, LNCaP-AI, and VCaP cells, confirming that
Usp12 affects AR transcriptional activity and as a result PSA
gene expression rather than protein secretion (Fig. 1C). To
summarize, Usp12 has been identified as a positive regulator of
AR in multiple PCa cell lines, and it was selected for further
validation and analysis.
Usp12 Stabilizes AR at the Protein Level—Ubiquitination of
AR causes a change in AR activity and stability and impacts
both survival and growth of PCa cells, as a result deubiquitina-
tion of those sites has an equally important role. We hypothe-
sized that Usp12 affects AR activity by deubiquitinating it and
as a result stabilizing AR protein. To determine the effects of
Usp12 on AR activity and protein stability we analyzed the lev-
els of endogenous AR in PCa cells depleted of Usp12. Silencing
of Usp12 resulted in a decrease of AR protein compared with
SCR in three PCa cell lines (Fig. 2, A–C). Stabilization of AR by
Usp12 relies on enzymatic activity of this DUB as mutant
Usp12C48A was not able to stabilize AR protein levels to the
same extent as the wild type (Fig. 2D). Additionally as little as
1:10 of Usp12 (50 ng) to AR (500 ng) was sufficient to cause this
effect (Fig. 2D). Similarly, when HEK293T cells were trans-
fected with AR and co-transfected with Usp12, Uaf-1, and
WDR20 the levels of AR increased compared with AR alone
(Fig. 2E). Even the increase inARprotein levels observed in cells
transfected with Uaf-1 and WDR20 can be attributed to the
stabilization of endogenous Usp12 caused by the overexpres-
sion of its cofactors as illustrated by Usp12 protein levels (Fig.
2E). To assess whether reduced receptor levels were a conse-
quence of compromised AR gene expression we analyzed AR
transcript level in LNCaP cells depleted of Usp12. Knockdown
of Usp12 or either one of its interacting partners had no statis-
tically significant effect on AR transcript levels suggesting that
Usp12 may function to enhance the stability of the AR in PCa
cells (data not shown). Additionally, we investigated the effects
of Usp12 depletion on AR half-life in PCa cells. In cells with
depleted Usp12 the pool of AR was smaller than in controls
even before the cycloheximide treatment and there was a trend
of decreased half-life of AR (Fig. 2F). In conclusion we have
shown that Usp12, with its interacting partners Uaf-1 and
WDR20, increases AR protein levels rather than regulating its
gene expression.
ARStabilization byUsp12Results in IncreasedARActivity—To
assess the effects of increased AR protein stability HEK293T
cells were transfected with an androgen-responsive luciferase
reporter containing three adjacent androgen-responsive ele-
ments (AREs) upstream from the luciferase gene. Additionally,
combinations of mammalian expression vectors including dual
FLAG-AR, FLAG-Usp12, and FLAG-Uaf-1 were co-trans-
fected, and receptor activity was assessed. Cells transfected
with Usp12 showed a trend of increased AR transcriptional
activity which was not statistically significant (Fig. 3A); how-
ever, whenUsp12 andUaf-1were co-transfected, AR transcrip-
tional activity was significantly increased to levels comparable
with that caused by the known AR co-regulator p300 (Fig. 3A).
This result is in agreement with previous reports that Usp12
requires the presence ofUaf-1 for its enzymatic activity (27). To
confirm a transcriptional co-regulatory role of Usp12 in the AR
signaling cascade, we assessed AR activity upon depletion of
Usp12 in the LNCaP variant cell line, LNCaP-7B7, which have a
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stably integrated luciferase gene under the control of the PSA
promoter. Usp12 silencing caused a significant decrease in AR
transcriptional activity both in steroid-depleted conditions and
after DHT stimulation (Fig. 3B). Additional confirmation of
Usp12 effects on AR transcriptional activity came from qPCR
analysis, where we observed that Usp12 silencing caused a sig-
nificant decrease of transcript levels of AR-regulated genes PSA
and TMPRSS2 (Figs. 3C and 1C) in multiple PCa cell lines. Fur-
ther analysis of Usp12 silencing in LNCaP cells cultured in ste-
roid-depleted conditions followed by DHT stimulation for
0–48 h showed a significant decrease in transcript levels of all
five androgen-regulated genes that were tested (Fig. 3D). Our
results confirm that the stabilization of AR caused by Usp12
results in enhanced transcriptional activity of AR and increased
transcript levels of AR-regulated genes. To determine the
underlying cause of the decreased transcriptional activity of AR
we performed ChIP analysis of AR recruitment to AREIII of
PSA enhancer after DHT stimulation. AR recruitment was
shown to be significantly decreased after Usp12 silencing com-
pared with SCR-treated control, further confirming the role of
Usp12 in the regulation of AR activity (Fig. 3E).
Stabilization of AR by Usp12 Affects Survival and Prolifera-
tion of Prostate Cells—Wehave shown thatUsp12 enhancesAR
activity by up-regulating receptor stability. We next assessed
the role of Usp12 in regulating the survival and proliferation of
PCa cell lines. Proliferation of three PCa cell lines was quanti-
fied by cell counting 96 h after Usp12 depletion. It was observed
that Usp12 silencing caused a significant decrease in cellular
proliferation in all three cell lines (Fig. 4A). To examine the
impact of Usp12 knockdown on LNCaP cell survival, we mea-
sured apoptosis by annexin V staining by flow cytometry.
Silencing of the Usp12 complex and Usp12 alone resulted in a
significant increase of apoptotic cells that was comparable with
the value obtained for cells with depleted AR (Fig. 4B).
Cell cycle analysis by PI staining revealed that depletion of
the Usp12 complex results in a significant increase of G1-ar-
rested PCa cells (Fig. 4C). Additionally, silencing of the Usp12
complex significantly increased the number of cells in sub-G1
phase, confirming that it causes an increase in cellular apopto-
sis (Fig. 4D).
One of the crucial properties of cancer cells is their ability to
form colonies which allows for cancer survival. We evaluated
the ability of LNCaP cells to form colonies after depletion of
Usp12. Cells with silenced Usp12 had a significantly decreased
ability to form colonies compared with SCR-treated control
(Fig. 4E). In conclusion, we have shown that AR stabilization by
Usp12 has a significant effect on proliferation and survival of
PCa cells. Usp12 is pro-proliferative, and cells deficient in it
have decreased ability to proliferate, have increased apoptosis
and G1 arrest, and are deficient in their ability to form colonies.
These data suggest that Usp12 has a key role in PCa disease
progression.
Usp12 Interacts with AR and Stabilizes It via Deubi-
quitination—We have shown that Usp12 stabilizes AR at the
protein level and as a result increases transcriptional activity
acting in a pro-survival manner in prostate cells. To determine
whether Usp12 interacts with AR we immunoprecipitated AR
and its interacting partners from the whole cell lysate. These
immunoprecipitants were immunoblotted for the presence of
Usp12. Both wild type Usp12 and its Cys-48 catalytically defi-
cient mutant Usp12C48A were shown to interact directly with
AR (Fig. 5A). Additionally, we confirmed the interaction
between the endogenousAR andUsp12 proteins in LNCaPPCa
cells (Fig. 5B). To determinewhether this interaction affects the
AR ubiquitination status we transfected COS-7 cells with ubiq-
uitin, AR, and wild type and the deubiquitinase-dead C48A
mutant Usp12. Cells were treated with proteosomal inhibitors
and lysed under denaturing conditions which ensures that only
covalent bonds will remain unaffected, and as a result only
direct ubiquitination of the AR rather than its interacting part-
ners can be visualized. Lysates were subsequently immunopre-
cipitated using an anti-ubiquitin antibody which allowed sepa-
ration of all directly ubiquitinated proteins and the levels of
ubiquitinatedAR visualized by immunoblotting the precipitant
for AR protein. Wild type but not Cys-48-deficient mutant of
Usp12 caused deubiquitination of AR (Fig. 5C).
To assess potential co-localization of the AR andUsp12 both
proteins were ectopically expressed in COS-7 cells. Immuno-
FIGURE 1. Usp12 is a co-regulator of AR as shown by an siRNA screen. A, results of the siRNA screen show the effects of DUB knockdown on AR activity
presented as a readout of PSA protein levels measured by an ELISA in LNCaP cells. B, LNCaP cells were treated with siRNA as indicated for 48 h prior to DHT
stimulation for 0–72 h as indicated followed by lysis and immunoblotting. C, LNCaP, LNCaP-AI, and VCaP cells were treated with siRNA as indicated for 96 h.
Total RNAwas extracted, andqRT-PCRwasperformed to analyze the transcript levels ofUsp12 and PSAnormalized toHPRT1. Data are presented asmean S.E.
(error bars) of three independent experiments normalized to scrambled (SCR). Statistical significance was analyzed using a t test.
FIGURE 2. Usp12 stabilizes AR at the protein level. A–C, LNCaP, LNCaP-AI,
and VCaP cells, respectively, were treatedwith siRNA as indicated. LNCaP and
VCaP cells were cultured in full media and LNCaP-AI in DCC. At 96 h cells were
lysed followed by immunoblotting. D, COS-7 cells were transfected with 500
ng of pFLAG-His-AR and increasing amounts (10–500 ng) of wild type and
C48A mutant Usp12 for 48 h. Reactions were balanced with empty pCMV
vector. E, HEK293T cells were transfected with pFLAG-His-AR, pFLAG-Usp12,
pFLAG-Uaf-1, and pHA-FLAG-WDR20 plasmids as indicated, and at 48 h cells
were lysed followed by Western blotting. F, LNCaP cells were treated with
siRNAas indicated for 96h followedby treatmentwith1Mcycloheximide for
0–4 h.
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fluorescence and confocal microscopy were employed to visu-
alize their cellular localization. It was observed that Usp12 and
AR co-localize in the cytoplasm in steroid-depleted conditions
(Fig. 5D). We have shown that enhanced levels of Usp12 result
in increasedARprotein stability and transcriptional activity. To
confirm whether this increase in Usp12 can be observed in vivo
we analyzed Usp12 positivity in benign and PCa patient sam-
ples. Usp12 protein levels were increased in PCa samples com-
pared with benign controls (Fig. 5E). To summarize, AR and
Usp12 interact, and enzymatically functional Cys-48 of Usp12
is not required for this interaction. Usp12 deubiquitinates AR
through this interaction and for this intact Cys-48 of Usp12 is
required, as a result AR is stabilized at the protein level and its
transcriptional activity is enhanced resulting in the activation
of pro-survival pathways in prostate cells.
DISCUSSION
It is widely accepted that the post-translational regulation of
AR protein stability is a crucial mechanism that regulates both
normal and malignant prostate cells. Even in CRPCa AR still
plays amajor role and remains themain focusof therapeutic strat-
egies, highlighting its importance as a drug target. Therapies
aimed at AR invariably fail as a result of AR becoming promiscu-
ous through mutations and acquiring the ability to become acti-
FIGURE 3. Stabilization of AR byUsp12 results in increased transcriptional activity of AR. A, HEK293T cells were transfectedwith pARE3-luc, pCMV--gal,
pFLAG-AR pFLAG-Usp12, and pFLAG-Uaf-1 as indicated and cultured for 48 h in steroid-depleted conditions followed by addition of DHT for 24 h. Results are
represented as a luciferase count/s normalized to -galactosidase activity. Data are mean S.E. (error bars) of three independent experiments normalized to
AR alone. Statistical significance was analyzed with a t test. B, LNCaP-7B7 cells were incubated in steroid-depleted medium followed by gene silencing after
24 h. At 48 hDHTwas applied and luciferase quantity determined 48h later. Datawere normalized to total protein content determinedusing a BCA assay. Data
are displayed as the -fold change in normalized luciferase activity comparedwith nontransfected cellswithoutDHT treatment. Error bars represent S.E. of three
independent experiments. C, LNCaP, LNCaP-AI, and VCaP cells were treatedwith siRNA as indicated for 96 h, total RNAwas extracted, and quantitative RT-PCR
was performed to analyze the transcript levels normalized to HPRT1. Data are a mean S.E. of three independent experiments normalized to SCR. Statistical
significance was analyzed with a t test. D, LNCaP cells were treated with siRNA for 48 h followed by stimulation with DHT for 0–48 h. Total RNA was extracted
andquantitative RT-PCRperformed to analyze the transcript levels normalized toHPRT1. Data are amean S.E. of three independent experiments normalized
to SCR. Statistical significancewas analyzed using a t test. E, LNCaP cells were treatedwith siRNA for 72 h in steroid-depletedmedium. DHTwas applied for 2 h
before cells were harvested, and ChIP for AR recruitment to AREIII of PSA enhancer or control IgG was performed. Data are represented as percentage
recruitment relative to input and are the mean of three independent experiments S.E.
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vatedbyavarietyof steroid-based ligandsaswell asanti-androgens
(2). As a result,more focus is needed onupstreamco-regulators of
AR as they could be potential drug targets.
Our study identified Usp12 as a novel positive regulator of
AR through an siRNA screen ofDUBs. Usp12was initially iden-
tified as a histone H2B and H2A deubiquitinase (25, 23);
recently, it was also reported to be a negative regulator ofNotch
signaling by impairing Notch trafficking and decreasing its cell
surface levels (24). Still little is known about the role ofUsp12 in
humans, but the role of the Usp12 homologue in yeast has been
researched in more detail with the enzyme shown to be
involved in actin dynamics, cell polarity, and endocytosis (28).
In S. pombe, silencing of the Usp12 homologue in combination
with Myosin-1 or Wiskott-Aldrich Syndrome protein (WAS)
was reported to be lethal. Our data also point to the importance
of Usp12 in cell survival as Usp12 depletion significantly
increased the percentage of apoptotic cells and causedG1 arrest
in PCa cells, suggesting an evolutionarily conserved role of
Usp12 in cell survival.
Usp12 DUB activity was previously shown to be very low in
the absence of its binding partners, WD40 proteins Uaf-1 and
WDR20 (27). Our reporter gene assays confirm this role of
Uaf-1, and we have shown that without Uaf-1, Usp12 was not
able to increase AR transcriptional activity whereas Usp12
knockdown alone was sufficient to decrease it. This confirms
the role thatUaf-1 plays in regulating the activity of Usp12. In S.
FIGURE 4. Stabilization of ARbyUsp12 affects prostate cancer cell survival andproliferation.A, LNCaP, LNCaP-AI, and VCaP cells were treatedwith siRNA
as indicated for 96 h, then silencing cellular proliferation was assessed by cell counting and normalized to SCR. Data are a mean  S.E. (error bars) of three
independent experiments. Statistical analysis was undertaken with a t test. ***, p 0.001; *, p 0.05. B, LNCaP cells were treated with siRNA as indicated for
96 h, then silencing levels of apoptotic cells were determined by flow cytometry detection of annexin V-positive cells, and the results were normalized to SCR.
Data aremean S.E. of four independent experiments. Statistical determinationwas undertakenwith an analysis of variance. C, LNCaP cells were treatedwith
siRNA as indicated for 96 h, following silencing cell cycle status was determined by flow cytometry analysis of PI staining. Ratio of cells in G1 versus S phasewas
determined, and results were normalized to SCR. Data are amean S.E. of three independent experiments. Statistical determinationwas undertakenwith an
analysis of variance. D, LNCaP cells were treated with siRNA as indicated for 96 h, following silencing the number of cells in sub-G1 phase was determined by
flow cytometry analysis of PI staining. Resultswere normalized to SCR. Data are amean S.E. of three independent experiments. Statistical determinationwas
undertakenwith analysis of variance. E, LNCaP cells were treatedwith siRNA as indicated for 72 h, following silencing cells were seeded at equal numbers with
varied densities in 6-well plates and incubated for 14 days. At day 14 cells were fixed and stainedwith crystal violet, and the number of colonies in each sample
was determined and normalized to SCR. Data are a mean S.E. of three independent experiments. Statistical analysis was undertaken with a t test. Images
show growth 14 days after seeding 4000 cells/2-mmwell.
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pombe, binding partners were shown to be necessary not only
for DUB activity but also to affect cellular localization of Usp12.
Uaf-1 deletion traps Usp12 in the nucleus, and analogously
WDR20 deletion traps Usp12 in the cytoplasm (28). It remains
to be established whether their role in Usp12 localization is
conserved in human.
DUBs have been previously shown to affect AR stability.
Usp10 is reported to bind to AR and positively regulate its tran-
FIGURE 5. Usp12 interacts with AR resulting in AR deubiquitination and AR stabilization. A, HEK293T cells were transfected with plasmids as indicated,
wild type (Usp12) and Cys-48-deficient mutant (Usp12M) of Usp12 were used. 48 h after transfection cells were harvested and lysates were immunoprecipi-
tated (IP) with 1 g of AR antibody followed by immunoblotting. B, LNCaP cells were harvested, and lysates were immunoprecipitated for AR and with a
nonspecific IgG. C, COS-7 cells were transfectedwith plasmids as indicated, andwild type (Usp12) and Cys-48-deficientmutant (Usp12M) of Usp12were used.
72 h after transfection cells were treated with MG132 and harvested 16 h later. Lysates were denatured and subsequently immunoprecipitated with 1 g of
ubiquitin antibody followed by immunoblotting.D, COS-7 cells were grown in steroid-depletedmedium and transfected with equal amounts of Usp12-FLAG
and AR plasmids. 48 h after transfection cells were fixed, and immunofluorescence followed by confocal microscopy were used to visualize the cellular
localization of both proteins. DAPI was used as a nuclear stain. Scale bars, 20 m. E, Usp12 immunohistochemistry of PCa and benign patient samples are
shown. Images are representatives of n 7 for each group. Scale bar, 50 m.
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scriptional activity (22). Recently, Usp10 effects on AR were
proposed to be indirect via Usp10-mediated deubiquitination
of H2A.Z leading to transcriptional activation of AR (35). This
hypothesis requires further investigation in the context of
Usp12 as it was also shown to deubiquitinate histones H2A and
H2B (23). It is possible that the Usp12 effect on AR could be a
combination of both direct deubiquitination and stabilization
of the receptor and indirect regulation through deubiquitina-
tion of histones which allows transcriptional activation. Simi-
larly, Usp26 is reported to assemble with AR and additional
cofactors in subnuclear foci resulting in AR deubiquitination
(21).We have also observed that Usp12 and AR co-localize and
interact, resulting in deubiquitination of AR. Co-localization of
AR and Usp12 occurs in the cytoplasm which can be explained
by the large portion of the proteasome being present in the
cytoplasm; it is also possible that for their co-localization in the
nucleus additional Usp12 cofactors would need to be co-trans-
fected to facilitate its shuttling similarly towhatwas observed in
S. pombe. This causes stabilization ofARat a protein level. It has
been previously published that silencing of AR results in G1
arrest and increased apoptosis; interestingly, we have observed
that Usp12 silencing has the same effects on PCa cells. These
cellular effects might be mediated by a combination of both
AR-mediated and AR-unrelated effects. AR stabilization by
Usp12 enhances transcriptional activity of AR and as a result
increases cellular proliferation. We report that Usp12 acts in a
pro-proliferative manner in PCa cells, which suggests that
Usp12 may play a crucial role in prostate cancer development,
progression, and metastasis. It remains to be established
whether mutations in Usp12 are associated with PCa occur-
rence and progression. Detailed impact of Usp12 in PCa and its
potential as a therapeutic target needs further assessment in the
future.
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